Peptide-based therapies are gaining growing attention in neurological research, offering innovative possibilities for conditions like Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative disorders. These therapeutic peptides are being studied for their ability to cross the blood-brain barrier, support neural repair, improve synaptic communication, and reduce oxidative stress and inflammation key contributors to brain degeneration.